Variational AI
Variational AI is developing advanced machine learning architectures to radically accelerate small molecule drug discovery. The company combines deep learning expertise with chemistry, pharmacology, and biology to optimize drug properties and streamline development.
Headquarters
Vancouver, British Columbia, Canada
Company Size
1-10 employees
Founded
2019
Variational AI applies advanced generative AI and machine learning to discover novel, drug‑like small molecules. Its multidisciplinary team of AI/ML and business specialists collaborates closely with biopharmaceutical partners to develop new therapeutics across multiple disease areas. Using their computational platform, they design and prioritize candidate molecules to accelerate hit‑to‑lead progression and reduce experimental burden. The company’s goal is to translate AI‑designed compounds into medicines that positively impact patient lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Variational AI.
48% below the average for this role
Senior Machine Learning Scientist
Revolution Medicines
Principal Machine Learning Scientist, Drug Discovery Analytics
Revolution Medicines
AI Research Scientist
Absentia Labs
Senior Machine Learning Scientist sf, ca
Manatal
Machine Learning Resident - Client: Blue Raven (1 year term)
Amii
Machine Learning Scientist - Small Molecule Drug Design
Roche